Health knowledge made personal
WellPage for Piperacillin
+ Bookmark › Share
Go
Search posts:

Piperacillin - Articles

bioMérieux, Inc. Issues Urgent Expanded Product Recall for VITEK® 2 Piperacillin/Tazobactam Test on Gram Negative Susc by FDA Posted Fri 08 Apr 2011 3:34pm FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Contact: Consumer: 1-800-682-2666 (option 3) Media: Allan Mohess 1-919-620-2937 allan.mohess@ ... Read on »
Voluntary Nationwide Recall of 15 Lots of Piperacillin and Tazobactam for Injection, USP 40.5 Grams Due to Possibility of Precip by FDA Posted Mon 29 Apr 2013 4:13pm WESTON, FL, April 26, 2013 /CNW/ - Apotex Corp. announced today that it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall of 15 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, NDC number 60505-0773-00 to the hospital / healthcare provider /user level. The impacted lots of Piperacillin and ... Read on »
Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon R by FDA Posted Tue 30 Apr 2013 9:35am [Posted 04/30/2013] AUDIENCE: Risk Manager, Nursing, Health Professional ISSUE: Apotex Corp. notified healthcare professionals it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall of 15 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, to the ho ... Read on »
VITEK 2 Gram Negative Susceptibility Cards Containing Piperacillin/Tazobactam (TZP): Recall - Incorrect Test Results Observed by FDA Posted Wed 10 Nov 2010 7:55am [Posted 11/10/2010] AUDIENCE: Risk Manager, Laboratory, Infectious Disease ISSUE: bioMérieux, Inc. VITEK 2 Gram Negative Susceptibility Cards that contain Piperacillin/Tazobactam are reporting incorrect results for testing the susceptibility of E. coli and K. pneumoniae to this drug. For E. coli, both falsely-resi ... Read on »
Class I Medical Device Recall: bioMérieux, Inc., VITEK 2 Gram Negative Susceptibility Cards Containing Piperacillin/Tazobac by Health & Human Services Posted Tue 09 Nov 2010 9:00pm Recall Class: I Date Recall Initiated: September 16, 2010 Product: VITEK 2 Gram Negative Susceptibility Cards Containing Piperacillin/Tazobactam (TZP) Affected card names and lot numbers (reference numbers) are listed in the Firm Press release under Useful Links below. See also below for link to product label p ... Read on »
Class I Medical Device Recall: bioMérieux, Inc., VITEK® 2 Gram Negative Susceptibility Cards Containing Piperacillin/T by Health & Human Services Posted Tue 03 May 2011 12:00am Recall Class: Class I Date Recall Initiated: March 10, 2011 Product: bioMérieux, Inc., VITEK® 2 Gram Negative Susceptibility Cards Containing Piperacillin/Tazobactam (TZP) AST-N183, REF 411 021 AST-N184, REF 411 154 These products were manufactured and distributed from September, 2010 through April, 2011. ... Read on »
Non-operative Treatment of Appendicitis by Dr. Erik McLaughlin Medical Doctor Posted Sat 13 Jun 2009 12:29am I was lucky enough to attend a great pediatric grand-rounds, yesterday, that discussed the non-operative management of acute appendicitis, in children. This idea seemed very interesting, to me, as it has obvious applications to healthcare providers in remote areas that may not have easy access to definitive surgical care. The information ... Read on »
bioMérieux, Inc. Issues Urgent Product Correction for VITEK® 2 Gram Negative Susceptibility Cards Containing Piperacil by FDA Posted Wed 27 Oct 2010 5:30pm Fleishman-Hillard Kimberly Mays Tel: +1 919-620-2937 kimberly.mays@fleishman.com FOR IMMEDIATE RELEASE - October 27, 2010 - DURHAM, N.C. - bioMérieux, Inc. on September 16, 2010, initiated a worldwide voluntary product correction of VITEK® 2 Gram Negative Susceptibility Cards containing the antibiotic Piperacillin/Tazo ... Read on »
September 2013 by FDA Posted Fri 01 Nov 2013 4:10pm Drug Safety Labeling Changes The summary view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. The “quick view” table below provides the drug name and ... Read on »
What You Need to Know About Pseudomonas Aeruginosa (PA) by Lauren B. Patient Expert Posted Mon 25 Aug 2008 7:27pm Pseudomonas Aeruginosa , commonly referred to in the cystic fibrosis community as simply "PA," is one of the most prevalent and difficult pathogens to eradicate. As an opportunistic pathogen, this bacteria takes hold mostly in people who are in weak health, or are already fighting another type of infection. In people who have normal immune s ... Read on »

Related Searches